-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
bioAffinity Technologies, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2022 to Q1 2025.
- bioAffinity Technologies, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2025 was -$1.64M, a 30% increase year-over-year.
- bioAffinity Technologies, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$7.26M, a 20.3% decline from 2023.
- bioAffinity Technologies, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$6.04M, a 48.3% decline from 2022.
- bioAffinity Technologies, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$4.07M, a 98.7% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)